Our Pricing

Wegovy Cheap With Discount Code WEIGHTLOSSNEW

Published on: June 03, 2026

Finding wegovy cheap uk discount code options has never been easier. At Cured Pharmacy, you can access genuine UK-licensed Wegovy (semaglutide) from £79.00 with code WEIGHTLOSSNEW, saving £79.00 on your first prescription. Every order includes a free clinical assessment by our UK-registered prescribers, discreet packaging, and transparent upfront pricing before you commit.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics a natural gut hormone called glucagon-like peptide-1, which regulates appetite and food intake by acting on receptors in the brain.

In the landmark STEP 1 clinical trial, participants using Wegovy achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight loss outcomes observed in pharmaceutical trials for obesity management. The medication works by slowing gastric emptying, reducing hunger signals, and increasing feelings of fullness after meals, helping patients adhere to reduced-calorie diets more comfortably.

Wegovy Dosing Schedule and What to Expect

Wegovy follows a carefully structured dose escalation protocol designed to minimise gastrointestinal side effects whilst optimising therapeutic benefit [2]. Treatment begins with a 0.25 mg once-weekly injection for the first four weeks, gradually increasing every four weeks through 0.5 mg, 1.0 mg, and 1.7 mg, before reaching the maintenance dose of 2.4 mg weekly.

This gradual titration approach allows your body to adapt to semaglutide's effects on gastric motility and appetite regulation. Most patients begin noticing reduced hunger and smaller portion sizes within the first 2-4 weeks, with measurable weight loss typically becoming evident by week 8-12 [2]. Your UK prescriber will monitor your progress and may adjust the escalation schedule based on your individual tolerance and response.

What Happens During Your Online Consultation

Our UK-registered clinical team will review your medical history, current medications, and weight loss goals during a confidential online assessment that takes under three minutes to complete. The prescriber will evaluate your BMI, any weight-related health conditions such as type 2 diabetes or hypertension, and assess whether Wegovy is clinically appropriate for you. All prescription decisions are made by qualified UK prescribers registered with the General Pharmaceutical Council, ensuring your treatment meets NHS clinical guidelines even when purchased privately.

Wegovy Cheap UK Discount Code: How to Save £10

Use discount code WEIGHTLOSSNEW at checkout to receive £79.00 off your first Wegovy prescription at Cured Pharmacy. This offer applies to all dose strengths and can be combined with our lowest price guarantee, ensuring you receive the most competitive UK pricing available for genuine semaglutide weight loss treatment.

Unlike promotional codes that require minimum purchase amounts or exclude prescription medications, WEIGHTLOSSNEW applies directly to your Wegovy order with no hidden terms. The discount is automatically calculated at checkout, reducing your first month's cost whilst you begin your weight management journey. Subsequent prescriptions continue at our standard transparent pricing, which remains among the lowest in the UK market for MHRA-licensed semaglutide.

Transparent Pricing Before Consultation

At Cured Pharmacy, you'll see the exact price of your Wegovy prescription before completing your clinical assessment—no surprise fees, no hidden consultation charges. This transparency allows you to make informed decisions about your weight loss treatment without the frustration of discovering costs only after providing personal medical information. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all pricing policies to ensure they remain fair, competitive, and clearly communicated to every patient.

Common Wegovy Side Effects and How to Manage Them

The most frequently reported side effects with Wegovy are gastrointestinal in nature, including nausea (44% of participants in STEP trials), diarrhoea (30%), vomiting (24%), and constipation (24%) [3]. These effects are typically mild to moderate, occur most commonly during dose escalation phases, and tend to diminish as your body adapts to the medication over 4-8 weeks.

To minimise digestive discomfort, eat smaller, more frequent meals rather than large portions, avoid high-fat and spicy foods during the first few weeks, and stay well-hydrated throughout the day. Injecting Wegovy at the same time each week and on the same day helps maintain steady semaglutide levels, reducing the likelihood of side effects. If nausea persists or becomes severe, contact your prescriber—they may recommend temporarily maintaining your current dose for an additional week before escalating, or prescribing anti-nausea medication if clinically appropriate.

Who Can Use Wegovy and Who Should Avoid It

Wegovy is licensed in the UK for adults aged 18 and over with a BMI of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as hypertension, type 2 diabetes, or obstructive sleep apnoea [1]. It is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those with severe gastrointestinal disease.

You should not use Wegovy if you are pregnant, planning pregnancy, or breastfeeding, as semaglutide's effects on foetal development have not been fully established [3]. Patients with a history of pancreatitis, severe renal impairment, or diabetic retinopathy should discuss these conditions with their prescriber during consultation, as additional monitoring may be required. Your UK clinical team will carefully evaluate all contraindications and drug interactions before approving your prescription.

Drug Interactions to Discuss With Your Prescriber

Wegovy can delay gastric emptying, which may affect the absorption of oral medications taken concurrently. If you take medications with a narrow therapeutic index—such as warfarin, levothyroxine, or oral contraceptives—inform your prescriber during your assessment. Patients using insulin or insulin secretagogues (such as sulphonylureas) may require dose adjustments to reduce the risk of hypoglycaemia when starting semaglutide, as both drug classes lower blood glucose through different mechanisms [3].

How to Store and Inject Wegovy Safely

Unopened Wegovy pens must be stored in a refrigerator between 2°C and 8°C until first use, and should never be frozen. Once you begin using a pen, it can be kept at room temperature (up to 30°C) or continued in the refrigerator for up to 28 days, after which it must be disposed of safely even if medication remains [4]. Always store pens in the original carton to protect from light, and keep them out of reach of children.

Wegovy is administered subcutaneously (under the skin) into the abdomen, thigh, or upper arm using the pre-filled pen device. Rotate injection sites each week to reduce the risk of lipodystrophy—changes in fatty tissue that can affect medication absorption. The pen is designed for single patient use only; never share your Wegovy pen with others, even if the needle is changed, as this poses a risk of blood-borne infection transmission. Dispose of used pens in a sharps container, which you can obtain free from most UK pharmacies or your local council.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Rubino, D., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
3. Electronic Medicines Compendium. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Medicines.org.uk. https://www.medicines.org.uk/emc/product/13799/smpc [accessed 13 August 2026]
4. Novo Nordisk. (2023). Wegovy (semaglutide) Patient Information Leaflet. Medicines and Healthcare products Regulatory Agency. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and individual results may vary. Weight loss outcomes depend on adherence to reduced-calorie diet and increased physical activity alongside medication use.